Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma

Purpose: The prognosis of hepatocellular carcinoma (HCC) has recently improved, and so clinicians have greater opportunity to treat HCC-derived spinal metastases. Therefore, predicting life expectancy is important for determining the optimal treatment strategy for such tumors. This study aimed to in...

Full description

Bibliographic Details
Main Authors: Hiroshi Uei, Yasuaki Tokuhashi
Format: Article
Language:English
Published: SAGE Publishing 2020-02-01
Series:Journal of Orthopaedic Surgery
Online Access:https://doi.org/10.1177/2309499019899167
id doaj-a4b7b2e9d3d546009bc581c980718324
record_format Article
spelling doaj-a4b7b2e9d3d546009bc581c9807183242020-11-25T03:23:47ZengSAGE PublishingJournal of Orthopaedic Surgery2309-49902020-02-012810.1177/2309499019899167Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinomaHiroshi UeiYasuaki TokuhashiPurpose: The prognosis of hepatocellular carcinoma (HCC) has recently improved, and so clinicians have greater opportunity to treat HCC-derived spinal metastases. Therefore, predicting life expectancy is important for determining the optimal treatment strategy for such tumors. This study aimed to investigate the prognostic factors for HCC-derived metastatic spine tumors and to develop a scoring system for predicting life expectancy in such cases. Methods: The posttreatment survival time and factors that might influence it were investigated in 62 patients with HCC-derived metastatic spine tumors who were treated at our department (surgery: 27 patients and conservative treatment: 35 patients), and a prognostic scoring system for predicting life expectancy was developed by combining the factors that significantly influenced survival. Results: In the univariate analyses, sex, the patient’s general condition, the presence/absence of major internal organ metastasis, the total revised Tokuhashi score, the serum albumin level, Child-Pugh class, spinal surgery, and bone-modifying agent (BMA) treatment were found to influence the posttreatment survival time. These factors were subjected to multivariate analysis, and a novel scoring system for predicting life expectancy based on the patient’s general condition, the serum albumin level (or Child-Pugh class), and BMA treatment was developed. In the retrospective analysis, the concordance rate between the patients’ life expectancy and actual survival times was 90.3%. Conclusion: The patient’s general condition, the serum albumin level (or Child-Pugh class), and BMA treatment influenced the posttreatment survival times of patients with HCC-derived metastatic spine tumors. A prognostic scoring system based on these factors was proposed.https://doi.org/10.1177/2309499019899167
collection DOAJ
language English
format Article
sources DOAJ
author Hiroshi Uei
Yasuaki Tokuhashi
spellingShingle Hiroshi Uei
Yasuaki Tokuhashi
Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
Journal of Orthopaedic Surgery
author_facet Hiroshi Uei
Yasuaki Tokuhashi
author_sort Hiroshi Uei
title Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
title_short Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
title_full Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
title_fullStr Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
title_full_unstemmed Prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
title_sort prognostic scoring system for metastatic spine tumors derived from hepatocellular carcinoma
publisher SAGE Publishing
series Journal of Orthopaedic Surgery
issn 2309-4990
publishDate 2020-02-01
description Purpose: The prognosis of hepatocellular carcinoma (HCC) has recently improved, and so clinicians have greater opportunity to treat HCC-derived spinal metastases. Therefore, predicting life expectancy is important for determining the optimal treatment strategy for such tumors. This study aimed to investigate the prognostic factors for HCC-derived metastatic spine tumors and to develop a scoring system for predicting life expectancy in such cases. Methods: The posttreatment survival time and factors that might influence it were investigated in 62 patients with HCC-derived metastatic spine tumors who were treated at our department (surgery: 27 patients and conservative treatment: 35 patients), and a prognostic scoring system for predicting life expectancy was developed by combining the factors that significantly influenced survival. Results: In the univariate analyses, sex, the patient’s general condition, the presence/absence of major internal organ metastasis, the total revised Tokuhashi score, the serum albumin level, Child-Pugh class, spinal surgery, and bone-modifying agent (BMA) treatment were found to influence the posttreatment survival time. These factors were subjected to multivariate analysis, and a novel scoring system for predicting life expectancy based on the patient’s general condition, the serum albumin level (or Child-Pugh class), and BMA treatment was developed. In the retrospective analysis, the concordance rate between the patients’ life expectancy and actual survival times was 90.3%. Conclusion: The patient’s general condition, the serum albumin level (or Child-Pugh class), and BMA treatment influenced the posttreatment survival times of patients with HCC-derived metastatic spine tumors. A prognostic scoring system based on these factors was proposed.
url https://doi.org/10.1177/2309499019899167
work_keys_str_mv AT hiroshiuei prognosticscoringsystemformetastaticspinetumorsderivedfromhepatocellularcarcinoma
AT yasuakitokuhashi prognosticscoringsystemformetastaticspinetumorsderivedfromhepatocellularcarcinoma
_version_ 1724604598168059904